Nexelis, a portfolio company of Ampersand Capital Partners and a leading provider of advanced assay development and laboratory testing services in the infectious, oncologic, and metabolic diseases fields, is pleased to announce its acquisition of AIT Bioscience, LLC
Located in Indianapolis and founded 25 years ago, AIT Bioscience is an integrated bioanalytical laboratory with LC-MS and immunoassay testing capabilities which operates a paperless FDA-inspected facility supported by state-of-the-art electronic systems.
Commenting on the news, Benoit Bouche, Nexelis President and Chief Executive Officer said, “this is our fourth acquisition since 2018 and we are excited for AIT Bioscience to join the Nexelis growth story. AIT Bioscience has a scientifically strong team and operates within a geography that we see as an attractive location for future growth. AIT Bioscience’s advanced testing capacity will help Nexelis further bolster its service offering in the bioanalytical segment and maintain competitive lead and turnaround times.”
Tim McGrath, Nexelis’ Chief Operating Officer who will oversee the Indianapolis operations, added, “I am happy and proud to have the responsibility to lead this new addition to Nexelis. This is an opportunity for me to work with experienced individuals, some of whom I have known for years. I am also excited to add large molecule mass spectrometry as a new service offering at Nexelis as this is a growing area where we now offer unique and specialized expertise.”
Want to publish your own articles on DistilINFO Publications?
Send us an email, we will get in touch with you.
The acquisition of AIT continues what has been a busy year at Nexelis. The company acquired Belgium-based immunogenicity and immune-oncology specialist ImmunXperts in March and has initiated a number of strategic partnerships to support the development of COVID-19 and other vaccines and biologics with global pharmaceutical companies and leading institutions such as the Bill and Melinda Gates Foundation and CEPI.
Source: Biospace
